BridgeMD
New treatment option for Developmental Language Disorder and Language Impairment
Official title Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II
ClinicalTrials.gov ID: NCT07048392
What this study is testing
- What it's testing
- Children with developmental language disorder (DLD; also referred to as specific language impairment) experience a significant deficit in language ability that is longstanding and harmful to the children's academic, social, and eventual economic well-being. Word learning is one of the principal weaknesses in these children.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 48 to 71. Healthy volunteers may be eligible.
You may be able to join if
- a significant deficit in language ability (language test score below cutoff for best sensitivity/specificity) or documented age-appropriate language...
- normal hearing.
- no evidence of neurological damage or disease.
- scores on tests of nonverbal intelligence above the intellectual disability range
- not within Autistic range on Autism screening test
You likely can't join if
- failed hearing screening
- known neurological damage or disease
- scores on tests of nonverbal intelligence below the intellectual disability range (standard score less than 75)
- autism spectrum disorder
- non-native English speaker
See the full eligibility criteria
- a significant deficit in language ability (language test score below cutoff for best sensitivity/specificity) or documented age-appropriate language ability.
- normal hearing.
- no evidence of neurological damage or disease.
- scores on tests of nonverbal intelligence above the intellectual disability range
- not within Autistic range on Autism screening test
- native English speaker (can be bilingual)
- failed hearing screening
- known neurological damage or disease
- scores on tests of nonverbal intelligence below the intellectual disability range (standard score less than 75)
- autism spectrum disorder
- non-native English speaker
The study team makes the final eligibility decision.
Where it's taking place
- West Lafayette, Indiana, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 48 months to 71 months. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include West Lafayette, Indiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.